United States Point Of Care Diagnostics Market to Grow at 6.90% CAGR by 2032| IMARC Group

United States Point Of Care Diagnostics Market Overview

Base Year: 2023

Historical Years: 2018-2023

Forecast Years: 2024-2032

Market Growth Rate: 6.90% (2025-2033)

The United States point-of-care diagnostics market is growing rapidly, fueled by advancements in technology and the rising demand for quick and accurate diagnostic solutions. Increasing adoption in healthcare settings enhances patient care by enabling real-time decision-making. This trend underscores the market’s critical role in advancing modern healthcare practices. According to the latest report by IMARC Group, the market is projected to grow at a CAGR of 6.90% from 2024 to 2032.

Download sample copy of the Report: https://www.imarcgroup.com/united-states-point-of-care-diagnostics-market/requestsample

United States Point Of Care Diagnostics Industry Trends and Drivers:

The United States point of care diagnostics market is experiencing steady growth, driven by expanding demand for rapid and accurate diagnostic solutions. The increasing prevalence of chronic diseases such as diabetes, cardiovascular conditions, and infectious diseases is propelling the need for accessible and immediate diagnostic testing. Urban centers with advanced healthcare infrastructure, including New York, Los Angeles, and Chicago, are leading in the adoption of point of care diagnostics. Efforts by healthcare authorities to promote decentralized healthcare services and improve patient outcomes are further supporting market growth.

Moreover, rising consumer awareness about preventive healthcare is encouraging the use of point of care diagnostics in both clinical and home settings. Additionally, the use of point of care diagnostics in chronic disease management, particularly for diabetes and cardiovascular monitoring, is growing steadily. Devices such as glucose meters and portable lipid profile analyzers are becoming essential tools in personalized care plans. The expansion of point of care testing into oncology and infectious disease diagnostics is further broadening the industry scope.

Key trends in the United States point of care diagnostics market size include the increasing focus on connectivity and data integration. Devices with wireless and cloud-based capabilities are allowing real-time data sharing between patients and healthcare providers, enhancing care coordination and decision-making. The rise of multiplex diagnostic platforms, which can test for multiple conditions simultaneously, is another significant growth-inducing trend, catering to the demand for comprehensive and efficient testing solutions. Moreover, advancements in molecular diagnostics are enabling point of care devices to detect genetic markers and pathogens with high precision, expanding their application in specialized care.

The integration of advanced technologies such as microfluidics and biosensors is further enhancing the efficiency and accuracy of point of care diagnostic devices. Portable and user-friendly devices are becoming increasingly popular, enabling healthcare providers to conduct tests at the bedside or in remote locations. The growing adoption of point of care diagnostics in ambulatory and emergency care settings is also contributing substantially to market expansion. Furthermore, government initiatives and funding programs aimed at improving healthcare access and early diagnosis are encouraging the development and adoption of innovative point of care diagnostic tools.

Additionally, partnerships between diagnostic companies and healthcare institutions are facilitating the development of tailored solutions. These solutions meet the specific needs of hospitals, clinics, and retail healthcare providers, encouraging widespread usage and facilitating overall industry expansion. 

United States Point Of Care Diagnostics Industry Segmentation:

The report has segmented the market into the following categories:

Product Type Insights:

• Blood-Glucose Monitoring Kit
• Cardio-Metabolic Monitoring Kit
• Pregnancy and Fertility Testing Kit
• Infectious Disease Testing Kit
• Cholesterol Test Strip
• Hematology Testing Kit
• Others

Platform Insights:

• Lateral Flow Assays
• Dipsticks
• Microfluidics
• Molecular Diagnostics
• Immunoassays

Prescription Mode Insights:

• Prescription-Based Testing
• OTC Testing

End User Insights:

• Professional Diagnostic Centers
• Home Care
• Research Laboratories
• Others

Regional Insights: 

• Northeast 
• Midwest 
• South 
• West 

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Ask analyst for your customized sample: https://www.imarcgroup.com/request?type=report&id=20479&flag=F

Browse more research report:

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: [email protected] 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145